first glp 1 on market BREAKING: The FDA has approved the oral GLP-1 pill for obesity, marking a major milestone in the weight-loss drug and a potential inflection point for treatment access. The daily pill How to Invest in GLP-1

Doctors aren't exactly sure how the drugs work "We know these medicines play on a receptor in the brainthe hypothalamusand we know that regulates our appetite, but scientists haven't figured out the precise mechanism for the way these medicines do that," Khan says

failure of this regulation allows excessive IL-1 and IL-18 production, amplifying systemic inflammation, which is particularly relevant in SLE and RA

Tell colleagues This educational programme has been supported by: This educational programme has been independently sponsored by the Boehringer Ingelheim and Lilly (BI & Lilly) Alliance

Side Effects: Excessive doses may cause neuromuscular weakness and, in severe cases, respiratory arrest, particularly when administered rapidly by infusion